However, a recent study demonstrated that phosphorylated PEA-15 sensitised ovarian cancer cells to a chemotherapeutic agent (Xie et al., 2013), suggesting that further investigation of the effect of phosphorylation of PEA-15 in inhibiting tumour development might be warranted. This evidence concerns the gene PEA15 and neoplasm.